Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome.
Lobbying Activity
Meeting with Michele Piergiovanni (Cabinet of President Ursula von der Leyen)
20 Nov 2025 · To give an update of recent development in the company and sector
Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)
25 Jun 2025 · Health
Meeting with Waldemar Buda (Member of the European Parliament, Shadow rapporteur)
24 Jun 2025 · Exchange views on how innovation in genomics can support the EU’s strategic priorities
Meeting with Elena Nevado Del Campo (Member of the European Parliament)
24 Jun 2025 · Proyecto Genoma Europeo
Meeting with Alexandra Hild (Cabinet of Commissioner Ekaterina Zaharieva), Andreas Schwarz (Cabinet of Commissioner Ekaterina Zaharieva)
23 Jun 2025 · Exchange on Life Sciences Strategy and next Framework Programme
Meeting with Oliver Schenk (Member of the European Parliament)
20 Mar 2025 · Genom sequencing
Meeting with Stine Bosse (Member of the European Parliament)
20 Mar 2025 · European health policy
Meeting with Carmen Laplaza Santos (Head of Unit Research and Innovation)
26 Feb 2025 · Exchange of views on how to leverage of genomics data to accelerate breakthroughs in precision medicine and to support the implementation of Horizon Europe
Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)
26 Feb 2025 · Genomic research in Europe
Meeting with Petar Vitanov (Member of the European Parliament, Shadow rapporteur)
20 Sept 2023 · EHDS
Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur)
27 Jun 2023 · European Health Data Space - EHDS
Response to Revision of Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC)
22 Feb 2022
Meeting with Katherine Power (Cabinet of Commissioner Mairead Mcguinness)
3 Dec 2021 · Cancer Screening tests, Illumina-GRAIL Merger
Meeting with Carole Mancel-Blanchard (Cabinet of Commissioner Elisa Ferreira)
3 Dec 2021 · Presentation of the merger case Illumina and Grail
Meeting with Chris Uregian (Cabinet of Vice-President Margaritis Schinas)
3 Dec 2021 · Healthcare benefits of Cancer test
Meeting with Eva Gerhards (Cabinet of Commissioner Helena Dalli)
3 Dec 2021 · Presentation of an early screening test by a cancer screening start-up. Its impact on health, early detection of cancer and especially on most vulnerable groups was discussed in the context of equality policy and the EU Beating Cancer strategy
Meeting with Joanna Stawowy (Cabinet of Commissioner Janusz Wojciechowski)
3 Dec 2021 · The public health benefits and competition issues arising out of the merger between Illumina and GRAIL
Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)
12 Nov 2021 · Challenges of the health industrial ecosystem
Meeting with Anthony Whelan (Cabinet of President Ursula von der Leyen) and Covington Burling LLP
29 Sept 2021 · Illumina/GRAIL transaction, which in addition to important competition policy questions